T-CURX GmbH, a German CAR-T Cell Biotech Spin-Off from University of Würzburg, Appoints Ulf Grawunder as CEO
11-Oct-2022 -
T-CURX GmbH announces the appointment of its co-founder, Ulf Grawunder, PhD, as the new CEO of the company.
T-CURX, which was co-founded by Prof. Michael Hudecek, MD, University of Würzburg, Germany, Prof. Christoph Rader, PhD, University of Florida, FL, U.S., and Ulf Grawunder, PhD, is a German ...
appointments
cancer
CAR-T cell therapies